Clinical trial
A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral…
NCT00475566 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00475566 |
|---|---|
| Title | A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System |
| Official title | A Study to Evaluate the Safety and Performance of the Dynalink®-E, Everolimus Eluting Peripheral Stent System for Treating Atherosclerotic de Novo or Restenotic Native Superficial Femoral and Proximal Popliteal Artery Lesions |
| Acronym | STRIDES |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Atherosclerosis, Peripheral Vascular Disease |
| Intervention type | Device |
| Interventions | Dynalink®-E everolimus-eluting peripheral stent, Dynalink®-E, everolimus-eluting peripheral stent |
| Enrollment | 104 |
| Start date | May 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Feb 1, 2010 |
| First posted | May 21, 2007 |
| Last update posted | Mar 10, 2011 |
| Countries | Austria, Belgium, Germany, Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: